Colorectal cancer screening in the Czech Republic: challenges and the role of general practitioners
Authors:
M. Stibůrková 1; O. Stibůrek 1,2; J. Trna 2,3
Authors‘ workplace:
Gastroenterologie Eden s. r. o., Brno
1; Nemocnice Boskovice s. r. o., Interní oddělení Gastroenterologická ambulance
2; LF MUNI Brno, Všeobecná interní klinika
3
Published in:
Prakt. Lék. 2025; 105(4): 154-157
Category:
Of different specialties
Overview
Stibůrková M, Stibůrek O, Trna J. Colorectal cancer screening in the Czech Republic: challenges and the role of general practitioners
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality in the Czech Republic. Although the introduction of population-based screening has reduced both incidence and mortality, suboptimal participation limits its effectiveness. This article summarizes the current benefits and limitations of the screening program, highlights the crucial role of general practitioners (GPs) in patient education and appropriate system utilization, and discusses strategies to improve adherence and efficiency. Emphasis is placed on the need to dispel myths about screening, address patient concerns regarding endoscopic procedures, and ensure strict adherence to screening and surveillance guidelines. The article also points out common errors that overload the system, such as unnecessary testing after recent colonoscopy or testing in patients with overt rectal bleeding.
Keywords:
screening – colonoscopy – colorectal cancer – General practitioners – fecal occult blood test
Sources
1. ÚZIS ČR. Národní screeningové centrum – výstupy a statistiky screeningu kolorektálního karcinomu (online). Dostupné z: https://www.onconet.cz/index.php?pg=data-projekty-vse&prid=51 [cit. 2025-10-25].
2. Zavoral M, Suchánek S, Májek O, a kol. Screening kolorektálního karcinomu v České republice: minulost, současnost a budoucnost. Gastroent Hepatol. 2022; 76(5): 365–371. Dostupné z: https://www.csgh.cz/cs/clanek/screening-kolorektalniho-karcinomu-v-ceske-republice-minulost-soucasnost - a-budoucnost-11574 [cit. 2025-10-25].
3. Ministerstvo zdravotnictví ČR. Doporučený standard pro screening kolorektálního karcinomu v ČR (Věstník MZ ČR č. 16/2024). Kolorektum.cz. 2024 (online). Dostupné z: https:// www.kolorektum.cz/news-detail/cs/327-aktualizovany-dopo ruceny-standard-pro-screening-kolorektalniho-karcinomu-v
4. Veselý M. Screening kolorektálního karcinomu v ČR – aktuální stav a perspektivy. Vnitř. Lék. 2024; 70(8): 511–517. Dostupné z: https://casopisvnitrnilekarstvi.cz/pdfs/vnl/2024/08/01.pdf [cit. 2025-10-25].
5. Suchánek Š, Grega T, Májek O, Dušek L, Zavoral M. Screening kolorektálního karcinomu. Onkologie 2013; 7(4): 176–178.
6. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013; 49(14): 3049–3054.
7. Česká gastroenterologická společnost. Guidelines pro dispenzarizaci pacientů po kolorektálním karcinomu. ČGS ČLS JEP 2022 (online). Dostupné z: https://www.cgs-cls.cz/dispenzarizace/crc [cit. 2025-10-25].
8. Česká televize. Plánované snížení věkové hranice pro vyšetření tlustého střeva (online). Dostupné z:https://www.ceskatelevize.cz/porady/1097181328-udalosti/225411000100625/cast/1124422 [cit. 2025-10-25].
9. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014; 160(3): 171.
10. Imperiale TF, Gruber RN, Stump TE, et al. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis. Ann Intern Med. 2019; 170(5): 319–329.
11. Half EE, Mlynarsky L, Naftali T, et al. False negative fecal occult blood test may be associated with increased mortality from colorectal cancer. Dig Dis Sci. 2013; 58(9): 2639–2645.
12. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014; 370(14): 1287–1297.
13. Redwood DG, Dinh TA, Kisiel JB, et al. Cost-effectiveness of multitarget stool DNA testing vs colonoscopy or fecal immunochemical testing for colorectal cancer screening in Alaska native people. Mayo Clin Proc. 2021; 96(5): 1203–1217.
14. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations from the US Multi-Society Task Force. Am J Gastroenterol. 2017; 112(7): 1016–1030.
15. Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy. Endoscopy 2017; 49(4): 378–397.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2025 Issue 4
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Most read in this issue
- Colorectal cancer screening in the Czech Republic: challenges and the role of general practitioners
- Endoscopic and microsurgical extirpation of a herniated intervertebral disc in the lumbar region
- The therapeutic potential of bee products
- Mental health of older adults: Barriers to psychotherapy and the role of general practitioners